Our sixth installment of Boston’s Life Science Disruptors event is coming up on October 17 at the Koch Institute for Integrative Cancer Research in Kendall Square. You don’t want to miss this unique blend of candid stories from some of New England’s most radical biotech company leaders, founders, and VC backers. You’ll get insights and perspective from the ground level of the life sciences scene that you just can’t anywhere else.
So grab your ticket and check out the agenda to hear how Beam Therapeutics, Celsius Therapeutics, and Arrakis Therapeutics are disrupting the industry.